Skip to main content
Back
Watch Compare

Sagimet Biosciences Inc.

SGMT
Nasdaq Manufacturing Chemicals
$5.30
▼ $0.34 (-6.03%)
Mkt Cap: 184.11 M
Price
$5.65
Mkt Cap
184.11 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Price History

Financial Trends

Analyst Price Target

9 analysts
Buy
Current
$5.30
+386.4%
Target
$25.78
$8.00
$27.00
$35.00
Forecast
Forward P/E -2.78
Forward EPS -$1.91
Est. Revenue 4.20 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$1.91
-$3.17 – -$0.92
 4.20 M 9
FY2026 -$1.69
-$2.25 – -$1.16
 0.0 9

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.40 -$0.29 +27.8%
Q32025 -$0.39 -$0.40 -2.2%
Q22025 -$0.50 -$0.32 +35.5%
Q12025 -$0.69 -$0.56 +18.5%

ETFs Holding This Stock

BRUSX BRUSX
1.60% weight
BRSIX BRSIX
0.16% weight
AVSCX AVSCX
0.02% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.01% weight

No fundamental snapshot available yet.

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue — 2.00 M 2.00 M
Net Income -51.04 M -45.57 M -27.88 M
EPS (Diluted) -1.58 -1.45 -2.66
Gross Profit — — —
Operating Income -56.89 M -54.45 M -30.74 M
EBITDA — — —
R&D Expenses 39.05 M 38.44 M 19.78 M
SG&A Expenses — — —
D&A — — —
Interest Expense — — —
Income Tax 0.0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 116.48 M 160.26 M 96.72 M
Total Liabilities — — 5.65 M
Shareholders' Equity 111.38 M 155.81 M 91.07 M
Total Debt — — —
Cash & Equivalents 35.02 M 75.84 M 75.14 M
Current Assets 116.40 M 152.77 M 96.65 M
Current Liabilities 5.10 M 4.45 M 5.65 M